Lundbeck Inc. And Otsuka Pharmaceutical Co., Ltd. To Co-Develop A Vaccine, Lu AF20513, Their Third Collaborative Development Project To Tackle Alzheimer’s Disease

Published: Dec 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valby, Denmark and Tokyo, Japan, 11 December 2013 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu AF20513, an investigational vaccine candidate against Alzheimer’s disease.

Help employers find you! Check out all the jobs and post your resume.

Back to news